ArticleIJID regions2025
Dengue diagnosis in Guinea in two returning travelers from Côte d'Ivoire: a case report.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Strengthening diagnostic capacity for viral hemorrhagic fevers in Forest Guinea: advances in Lassa fever case detection.Npj viruses · 2026Article
- Genomic Surveillance of Lassa Virus through In-Country Sequencing, Guinea.Emerging infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Funding
Abstract
Dengue's true burden on the African continent is likely underestimated. The majority of cases originate from West Africa, mostly from Burkina Faso. We report here the detection in Guinea of two imported cases of dengue in travelers returning from Côte d'Ivoire, one fatal (case 1) and one mild (case 2). Case 1 lived in Côte d'Ivoire and was diagnosed during a trip in Conakry, Guinea, on 14 August 2023, 9 days after symptom onset. He died on 21 August of an illness related to severe dengue; dengue virus serotype 3 (DENV-3) was further identified. Case 2 was diagnosed in N'Zérékoré, a forested region of Guinea, with serotype 1 (DENV-1) on 11 July 2024, 2 days after disease onset, while returning from Côte d'Ivoire. He was hospitalized for 9 days until full recovery. In-country phylogenetic analysis of case 2 DENV-1 revealed its linkage with urban dengue viruses known to circulate in West Africa. This timely detection, supported by enhanced diagnostics and genomic surveillance capacity in Guinea's laboratory network, highlights the need to strengthen surveillance systems for early detection of emerging viral infections, and emphasizes the importance of further monitoring dengue circulation dynamics in West Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.